ROVONC

DEAD

Serial Number

75619611

Owner

EISAI CORPORATION OF NORTH AMERICA

Attorney

Mark I. Feldman

First Use Date

Jan 21, 2003

Filing Date

Jan 12, 1999

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

ROVONC Trademark

Serial Number: 75619611 • Registration: 2729432

ROVONC is a trademark filed by EISAI CORPORATION OF NORTH AMERICA on January 12, 1999. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

EISAI CORPORATION OF NORTH AMERICA (26 trademarks)

100 TICE BOULEVARD
WOODCLIFF LAKE, NJ 07677

Entity Type: 03

MGI PHARMA, INC. (23 trademarks)

SUITE 100
BLOMMINGTON, MN 55437

Entity Type: 03

Legal Representation

Attorney of Record

Mark I. Feldman

3,507 trademarks filed View all →

Trademark Details

Filing Date

January 12, 1999

Registration Date

June 24, 2003

First Use Anywhere

January 21, 2003

First Use in Commerce

January 21, 2003

Published for Opposition

November 9, 1999

Cancellation Date

January 31, 2010

Goods & Services

pharmaceutical preparation for the treatment of cancer

Filing History

CANCELLED SEC. 8 (6-YR)

Jan 31, 2010 C8..

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Mar 18, 2009 ASGN

CASE FILE IN TICRS

Jun 23, 2008 CFIT

CORRECTION UNDER SECTION 7 - PROCESSED

Aug 28, 2003 COC.

SEC 7 REQUEST FILED

Jul 18, 2003 AMD7

PAPER RECEIVED

Jul 18, 2003 MAIL

REGISTERED-PRINCIPAL REGISTER

Jun 24, 2003 R.PR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Apr 17, 2003 CNPR

ASSIGNED TO EXAMINER

Apr 17, 2003 DOCK

ASSIGNED TO EXAMINER

Apr 16, 2003 DOCK

STATEMENT OF USE PROCESSING COMPLETE

Apr 14, 2003 SUPC

USE AMENDMENT FILED

Jan 27, 2003 IUAF

PAPER RECEIVED

Jan 27, 2003 MAIL

SOU EXTENSION 5 GRANTED

Jul 8, 2002 EX5G

SOU EXTENSION 5 FILED

Jun 19, 2002 EXT5

PAPER RECEIVED

Jun 19, 2002 MAIL

PAPER RECEIVED

Mar 18, 2002 MAIL

SOU EXTENSION 4 GRANTED

Jan 9, 2002 EX4G

SOU EXTENSION 4 FILED

Dec 21, 2001 EXT4

SOU EXTENSION 3 GRANTED

Sep 24, 2001 EX3G

REINSTATED

Sep 24, 2001 REIN

SOU EXTENSION 3 FILED

Jul 3, 2001 EXT3

SOU EXTENSION 2 GRANTED

Jun 10, 2001 EX2G

ABANDONMENT - NO USE STATEMENT FILED

Jun 5, 2001 ABN6

SOU EXTENSION 2 FILED

Dec 21, 2000 EXT2

SOU EXTENSION 1 GRANTED

Oct 6, 2000 EX1G

SOU EXTENSION 1 FILED

Jul 27, 2000 EXT1

NOA MAILED - SOU REQUIRED FROM APPLICANT

Feb 1, 2000 NOAM

PUBLISHED FOR OPPOSITION

Nov 9, 1999 PUBO

NOTICE OF PUBLICATION

Oct 8, 1999 NPUB

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 12, 1999 CNSA

ASSIGNED TO EXAMINER

Jul 2, 1999 DOCK

Related Trademarks

More from this Owner

MGI PHARMA BIOLOGICS

Serial #78460286

Serial #78460294

More in Same Class

ASAVIVE

NEUVENEX

BACEX

DR. ROGERS GOLD FORMULA REMOVES HEART BLOCKING PLAQUE METAL ORAL KS

KIRBAN

SEVEN PRECIOUS KS RARE METALS KS I.V. CANCER TREATMENT NOT PATIENT TOXIC